Philip Campbell Selected Research

Therapeutics

5/2024	Daratumumab, cyclophosphamide, bortezomib and dexamethasone for non-transplant eligible myeloma (AMaRC 03-16).
11/2020	Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
5/2015	The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Campbell Research Topics

Disease

9	Multiple Myeloma 12/2021 - 05/2015
5	Infections 12/2022 - 05/2005
4	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2020
3	Neoplasms (Cancer) 12/2022 - 05/2005
2	Hemorrhage 07/2023 - 12/2022
2	Atrial Fibrillation 12/2022 - 04/2006
2	Disease Progression 11/2020 - 01/2018
2	Neutropenia 01/2018 - 12/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2024
1	Synucleinopathies 03/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022
1	Hypertension (High Blood Pressure) 12/2022
1	Skin Neoplasms (Skin Cancer) 12/2022
1	Frailty 11/2021
1	Pain (Aches) 08/2021
1	Acute Kidney Injury (Acute Renal Failure) 08/2021
1	Neuroblastoma 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2020
1	Bronchitis 11/2020
1	Cough 11/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Anemia 01/2018
1	Residual Neoplasm 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Febrile Neutropenia 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2012
1	Mumps 12/2011
1	Rubella (German Measles) 12/2011
1	Measles 12/2011
1	Brain Diseases (Brain Disorder) 11/2009
1	Sepsis (Septicemia) 05/2007

Drug/Important Bio-Agent (IBA)

6	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 07/2012
6	Bortezomib (Velcade)FDA Link 11/2021 - 05/2015
5	Prednisone (Sone)FDA LinkGeneric 11/2021 - 12/2015
4	daratumumabIBA 11/2021 - 01/2018
2	Lenalidomide (CC 5013)FDA Link 12/2021 - 12/2015
2	Rituximab (Mabthera)FDA Link 01/2020 - 05/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 02/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 02/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 05/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 05/2015
2	fludarabineIBA 02/2013 - 05/2005
1	SynucleinsIBA 03/2024
1	alpha-SynucleinIBA 03/2024
1	Vitamin K FDA Link 07/2023
1	AnticoagulantsIBA 07/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2022
1	acalabrutinibIBA 12/2022
1	Prednisolone (Predate)FDA LinkGeneric 12/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2021
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020
1	Ambroxol (Mucosolvan)IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	plerixafor FDA Link 01/2018
1	Amsacrine (AMSA)IBA 02/2013
1	Fibroblast Growth Factor 7 FDA Link 07/2012
1	Busulfan (Busulfex)FDA Link 07/2012
1	VaccinesIBA 12/2011
1	Prolyl OligopeptidasesIBA 11/2009
1	Proline (L-Proline)FDA Link 11/2009
1	Peptides (Polypeptides)IBA 11/2009
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 04/2006
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2006

Therapy/Procedure

7	Stem Cell Transplantation 12/2021 - 01/2018
3	Therapeutics 05/2024 - 05/2015
3	Drug Therapy (Chemotherapy) 11/2020 - 07/2012
1	Blood Component Removal (Apheresis) 01/2018
1	Autologous Transplantation 12/2015
1	Salvage Therapy 02/2013
1	Catheters 05/2007
1	Electric Countershock (Cardioversion) 04/2006